Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06931275 · ClinicalTrials.gov registry record · NA
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
A NA study of Diabetes Mellitus, Type 1, sponsored by T1D Exchange, United States.
- Recruiting
- Registry status
- NA
- Development phase
- 1,178
- Enrollment target
- 2
- Study locations
NCT06931275 is a NA study of Diabetes Mellitus, Type 1 that is actively recruiting participants, run by T1D Exchange, United States. The registered enrollment target is 1,178 participants, roughly in line with the 1,256-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target. The trial reports 2 study locations across 1 state.
The verdict
NCT06931275, a NA study of Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by T1D Exchange, United States.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,178 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions. The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA). The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies. Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.
Conditions Studied
Interventions
- OTHER EMR-based BPA model
- BEHAVIORAL Placebo (EMR-based without BPA model)
Study Locations (2)
Massachusetts
- T1D Exchange - Boston
- T1D Exchange - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,178 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06931275
The ClinicalTrials.gov registry entry for NCT06931275 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,178 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,256-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target. The listed sponsor is T1D Exchange, United States, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 2 interventions - of which EMR-based BPA model is the first listed.
NCT06931275 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06931275 about?
NCT06931275 is a clinical study titled "Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes". The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind pres...
What is the current status of trial NCT06931275?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,178 participants. The study started on 2024-08-13. Estimated completion is 2027-07-30.
What conditions does trial NCT06931275 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT06931275?
The interventions under investigation include: EMR-based BPA model (OTHER), Placebo (EMR-based without BPA model) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06931275?
This trial is sponsored by T1D Exchange, United States, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06931275 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
-
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
RECRUITING · NA
-
National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.
RECRUITING · NA
-
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
RECRUITING · NA
-
Closed Loop and Education for Hypoglycemia Awareness Restoration
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.